Innovis Asset Management LLC Bristol Myers Squibb CO Transaction History
Innovis Asset Management LLC
- $260 Billion
- Q3 2023
A detailed history of Innovis Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Innovis Asset Management LLC holds 5,248 shares of BMY stock, worth $208,135. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,248
Previous 5,158
1.74%
Holding current value
$208,135
Previous $330 Million
7.66%
% of portfolio
0.12%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.38 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.45 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.63 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.52 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.78 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $84.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...